Skip to content
PubMed This is a summary of 39 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 39 referenced papers

Top Authors

Sergio D. Rosenzweig
National Institutes of Health
Hye Sun Kuehn
National Institutes of Health
Julie E. Niemela
National Institutes of Health
Tomohiro Morio
Tokyo Medical and Dental University
Motoi Yamashita
Tokyo Medical and Dental University
Hirokazu Kanegane
Institute of Science Tokyo
Charlotte Cunningham‐Rundles
Icahn School of Medicine at Mount Sinai
Capucine Pïcard
Hôpital Necker-Enfants Malades
Christoph A. Klein
Ludwig-Maximilians-Universität München

Top Institutions

Ranked by publications Top 10 institutions
06

Institute of Science Tokyo

Tokyo, Japan

8 papers

References

References (39)
  1. 1

    Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

    Kuehn HS, Boisson B, Cunningham-Rundles C, et al.

    The New England journal of medicine 2016; (374(11)):1032-1043 doi:10.1056/NEJMoa1512234.

    PMID: 26981933
  2. 2

    How to use immunoglobulin levels in investigating immune deficiencies.

    Ladomenou F, Gaspar B

    Archives of disease in childhood. Education and practice edition 2016; (101(3)):129-35 doi:10.1136/archdischild-2015-309060.

    PMID: 26987724
  3. 3

    Vaccination in Primary Immunodeficiency Disorders.

    Sobh A, Bonilla FA

    The journal of allergy and clinical immunology. In practice 2016; (4(6)):1066-1075 doi:10.1016/j.jaip.2016.09.012.

    PMID: 27836056
  4. 4

    Abnormal hematopoiesis and autoimmunity in human subjects with germline IKZF1 mutations.

    Hoshino A, Okada S, Yoshida K, et al.

    The Journal of allergy and clinical immunology 2017; (140(1)):223-231 doi:10.1016/j.jaci.2016.09.029.

    PMID: 27939403
  5. 5

    When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

    Jolles S, Chapel H, Litzman J

    Clinical and experimental immunology 2017; (188(3)):333-341 doi:10.1111/cei.12915.

    PMID: 28000208
  6. 6

    Reference values for B-cell surface markers and co-receptors associated with primary immune deficiencies in healthy Turkish children.

    Azarsiz E, Karaca NE, Aksu G, Kutukculer N

    International journal of immunopathology and pharmacology 2017; (30(2)):194-200 doi:10.1177/0394632017707609.

    PMID: 28449602
  7. 7

    Influenza Vaccination in Patients with Common Variable Immunodeficiency (CVID).

    Mieves JF, Wittke K, Freitag H, et al.

    Current allergy and asthma reports 2017; (17(11)):78 doi:10.1007/s11882-017-0749-3.

    PMID: 28983790
  8. 8

    Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.

    Boutboul D, Kuehn HS, Van de Wyngaert Z, et al.

    The Journal of clinical investigation 2018; (128(7)):3071-3087.

    PMID: 29889099
  9. 9

    Assessing the Functional Relevance of Variants in the IKAROS Family Zinc Finger Protein 1 (IKZF1) in a Cohort of Patients With Primary Immunodeficiency.

    Eskandarian Z, Fliegauf M, Bulashevska A, et al.

    Frontiers in immunology 2019; (10()):568 doi:10.3389/fimmu.2019.00568.

    PMID: 31057532
  10. 10

    Familial Immune Thrombocytopenia Associated With a Novel Variant in IKZF1.

    Sriaroon P, Chang Y, Ujhazi B, et al.

    Frontiers in pediatrics 2019; (7()):139 doi:10.3389/fped.2019.00139.

    PMID: 31069201
  11. 11

    Autoimmunity in common variable immunodeficiency.

    Agarwal S, Cunningham-Rundles C

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2019; (123(5)):454-460 doi:10.1016/j.anai.2019.07.014.

    PMID: 31349011
  12. 12

    Comprehensive assessment of respiratory complications in patients with common variable immunodeficiency.

    Moazzami B, Mohayeji Nasrabadi MA, Abolhassani H, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2020; (124(5)):505-511.e3 doi:10.1016/j.anai.2020.01.019.

    PMID: 32007567
  13. 13

    IKAROS Family Zinc Finger 1-Associated Diseases in Primary Immunodeficiency Patients.

    Nunes-Santos CJ, Kuehn HS, Rosenzweig SD

    Immunology and allergy clinics of North America 2020; (40(3)):461-470 doi:10.1016/j.iac.2020.04.004.

    PMID: 32654692
  14. 14

    Common Variable Immunodeficiency, Autoimmune Hemolytic Anemia, and Pancytopenia Associated With a Defect in IKAROS.

    Yilmaz E, Kuehn HS, Odakir E, et al.

    Journal of pediatric hematology/oncology 2021; (43(3)):e351-e357 doi:10.1097/MPH.0000000000001976.

    PMID: 33122583
  15. 15

    Germline IKZF1 mutations and their impact on immunity: IKAROS-associated diseases and pathophysiology.

    Kuehn HS, Nunes-Santos CJ, Rosenzweig SD

    Expert review of clinical immunology 2021; (17(4)):407-416 doi:10.1080/1744666X.2021.1901582.

    PMID: 33691560
  16. 16

    Abnormal SCID Newborn Screening and Spontaneous Recovery Associated with a Novel Haploinsufficiency IKZF1 Mutation.

    Kuehn HS, Gloude NJ, Dimmock D, et al.

    Journal of clinical immunology 2021; (41(6)):1241-1249 doi:10.1007/s10875-021-01035-1.

    PMID: 33855675
  17. 17

    There is no gene for CVID - novel monogenetic causes for primary antibody deficiency.

    Ramirez NJ, Posadas-Cantera S, Caballero-Oteyza A, et al.

    Current opinion in immunology 2021; (72()):176-185 doi:10.1016/j.coi.2021.05.010.

    PMID: 34153571
  18. 18

    Pathogenic germline IKZF1 variant alters hematopoietic gene expression profiles.

    Brodie SA, Khincha PP, Giri N, et al.

    Cold Spring Harbor molecular case studies 2021; (7(4)) doi:10.1101/mcs.a006015.

    PMID: 34162668
  19. 19

    Vaccination in PADs.

    Milito C, Soccodato V, Collalti G, et al.

    Vaccines 2021; (9(6)) doi:10.3390/vaccines9060626.

    PMID: 34207916
  20. 20

    Inborn errors of IKAROS and AIOLOS.

    Yamashita M, Morio T

    Current opinion in immunology 2021; (72()):239-248 doi:10.1016/j.coi.2021.06.010.

    PMID: 34265590
  21. 21

    Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.

    Schiavo E, Martini B, Attardi E, et al.

    Frontiers in immunology 2021; (12()):790455 doi:10.3389/fimmu.2021.790455.

    PMID: 35058929
  22. 22

    Clinical Courses of IKAROS and CTLA4 Deficiencies: A Systematic Literature Review and Retrospective Longitudinal Study.

    Hoshino A, Toyofuku E, Mitsuiki N, et al.

    Frontiers in immunology 2021; (12()):784901 doi:10.3389/fimmu.2021.784901.

    PMID: 35087518
  23. 23

    Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation.

    Hoshino A, Boutboul D, Zhang Y, et al.

    Science immunology 2022; (7(69)):eabi7160 doi:10.1126/sciimmunol.abi7160.

    PMID: 35333544
  24. 24

    Clinical exome sequencing of 1000 families with complex immune phenotypes: Toward comprehensive genomic evaluations.

    Similuk MN, Yan J, Ghosh R, et al.

    The Journal of allergy and clinical immunology 2022; (150(4)):947-954 doi:10.1016/j.jaci.2022.06.009.

    PMID: 35753512
  25. 25

    Long Term Norovirus Infection in a Patient with Severe Common Variable Immunodeficiency.

    Ottosson L, Hagbom M, Svernlöv R, et al.

    Viruses 2022; (14(8)) doi:10.3390/v14081708.

    PMID: 36016330
  26. 26

    Current clinical spectrum of common variable immunodeficiency in Spain: The multicentric nationwide GTEM-SEMI-CVID registry.

    Cabañero-Navalon MD, Garcia-Bustos V, Nuñez-Beltran M, et al.

    Frontiers in immunology 2022; (13()):1033666 doi:10.3389/fimmu.2022.1033666.

    PMID: 36389743
  27. 27

    Case report: IKZF1-related early-onset CID is expected to be missed in TREC-based SCID screening but can be identified by determination of KREC levels.

    Äng C, Zetterström RH, Ramme K, et al.

    Frontiers in immunology 2023; (14()):1257581 doi:10.3389/fimmu.2023.1257581.

    PMID: 37771582
  28. 28

    IKAROS gain of function disease: Allogeneic hematopoietic cell transplantation experience and expanded clinical phenotypes.

    Klangkalya N, Stoddard J, Niemela J, et al.

    Clinical immunology (Orlando, Fla.) 2024; (260()):109922 doi:10.1016/j.clim.2024.109922.

    PMID: 38320737
  29. 29

    The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing.

    Ameratunga R, Woon ST, Leung E, et al.

    Seminars in arthritis and rheumatism 2024; (65()):152387 doi:10.1016/j.semarthrit.2024.152387.

    PMID: 38330740
  30. 30

    IgG4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant.

    García-Solís B, Tapia-Torres M, García-Soidán A, et al.

    The Journal of allergy and clinical immunology 2024; (154(3)):819-826 doi:10.1016/j.jaci.2024.03.018.

    PMID: 38579942
  31. 31

    IKAROS protein stability is regulated by its early N-terminal region and C-terminal dimerization domain.

    Klangkalya N, Esteve-Sole A, Gil Silva AA, et al.

    Clinical immunology (Orlando, Fla.) 2025; (274()):110469 doi:10.1016/j.clim.2025.110469.

    PMID: 40024461
  32. 32

    JAK inhibitor ameliorates inflammatory bowel disease in a patient with IKZF1 haploinsufficiency.

    Inoue S, Ikai M, Nambu R, et al.

    Clinical immunology (Orlando, Fla.) 2025; (274()):110470 doi:10.1016/j.clim.2025.110470.

    PMID: 40037506
  33. 33

    Common variable immunodeficiency.

    Solanich X, Antolí A, Alsina L

    Medicina clinica 2025; (165(5)):107168 doi:10.1016/j.medcli.2025.107168.

    PMID: 41045774
  34. 34

    Immunodeficiencies in Adults: Key Considerations for Diagnosis and Management.

    Regina J, Doms J, Kampouri E, et al.

    Clinical reviews in allergy & immunology 2025; (68(1)):92 doi:10.1007/s12016-025-09103-9.

    PMID: 41107625
  35. 35

    IKAROS Associated Immunodeficiency and Thrombotic Thrombocytopenic Purpura.

    Spivak I, Magen D, Weiss K, et al.

    Pediatric blood & cancer 2025; e32173 doi:10.1002/pbc.32173.

    PMID: 41261933
  36. 36

    Single-Cell RNA Sequencing Informs Precision Targeting of Monogenic Lupus Associated With IKZF1 Haploinsufficiency.

    Zheng Q, Tan Y, Wang Z, et al.

    Arthritis & rheumatology (Hoboken, N.J.) 2026; (78(6)):1231-1244 doi:10.1002/art.70017.

    PMID: 41392616
  37. 37

    The 2024 update of IUIS phenotypic classification of human inborn errors of immunity.

    Bousfiha AA, Jeddane L, Moundir A, et al.

    Journal of human immunity 2025; (1(1)):e20250002 doi:10.70962/jhi.20250002.

    PMID: 41608113
  38. 38

    Diagnostic and therapeutic journey of infantile endobronchial tuberculosis: a case report.

    Li Z, Zhang Y, Xu D, Huang B

    Frontiers in pediatrics 2026; (14()):1778717 doi:10.3389/fped.2026.1778717.

    PMID: 41878461
  39. 39

    IKZF-associated inborn errors of immunity.

    Yamashita M, Morio T

    Journal of human immunity 2025; (1(3)):e20250063 doi:10.70962/jhi.20250063.

    PMID: 42169761